Michael Hymbaugh
Internal Medicine · Baton Rouge, LANPI 1053529727
Payments from drug & device makers
Across 264 payments — averaging $60.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$12K
- Viiv Healthcare Company$2K
- Janssen Products, LP$547
- Merck$376
- Napo Pharmaceuticals Inc$285
- Johnson & Johnson$164
- plus $395 from 10 others
What the payments were for
- Consulting fees$7,11044%
- Speaking & faculty fees$991%
- Travel & lodging$2,53016%
- Food & beverage$5,95037%
- Education$3192%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 106 | $12,253 |
| Viiv Healthcare Company | 92 | $1,989 |
| Janssen Products, LP | 5 | $547 |
| Merck | 19 | $376 |
| Napo Pharmaceuticals Inc | 11 | $285 |
| Johnson & Johnson | 10 | $164 |
| Theratechnologies Inc. | 7 | $125 |
| Abbott | 3 | $110 |
| Lilly USA, LLC | 3 | $45 |
| Insulet Corporation | 1 | $25 |
| Janssen Scientific Affairs, LLC | 2 | $18 |
| AstraZeneca | 1 | $16 |
| Exact Sciences | 1 | $15 |
| AbbVie | 1 | $14 |
| Novartis | 1 | $13 |
| Ascendis Pharma Endocrinology Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,008 in reported general payments places this provider in the 95th percentile of 1,528 internal medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 98 | $345,075 |
| JulucaDolutegravir/Rilpivirine | 97 | $303,198 |
| DovatoDolutegravir Sodium/Lamivudine | 67 | $180,530 |
| TivicayDolutegravir Sodium | 50 | $113,529 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 32 | $111,159 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 17 | $85,069 |
| CabenuvaCabotegravir/Rilpivirine | 17 | $80,698 |
| DescovyEmtricitabine/Tenofov Alafenam | 31 | $60,303 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 13 | $48,647 |
| OzempicSemaglutide | 34 | $30,125 |
| RybelsusSemaglutide | 26 | $25,049 |
| PifeltroDoravirine | 16 | $24,883 |
| TrulicityDulaglutide | 26 | $20,018 |
| JardianceEmpagliflozin | 21 | $12,322 |
| Incruse ElliptaUmeclidinium Bromide | 14 | $4,711 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyJuluca, Dovato, Tivicay, Cabenuva, Triumeq | $1,989 | $726,601244 claims |
| GileadBiktarvy, Descovy | $12,253 | $405,378129 claims |
| Janssen Products, LPSymtuza | $547 | $85,06917 claims |
| MerckPifeltro | $376 | $24,88316 claims |
| Lilly USA, LLCTrulicity | $45 | $20,01826 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,528 internal medicine providers in Louisiana.
Other internal medicine in Baton Rouge
- Katherine PearceBaton Rouge$12M
- Donna RyanBaton Rouge$991K
- Gertrude Chimeka AnyanwokeBaton Rouge$611K
- Deepesh PatelBaton Rouge$304K
- John SchwabBaton Rouge$122K
- Barret MurphyBaton Rouge$43K
- Brian GremillionBaton Rouge$27K
- Raoul ManalacBaton Rouge$27K
- Bradley MeekBaton Rouge$20K
- William SmithNew Orleans$50.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.